2seventy bio Presents Broad Range of New Data Highlighting N

 bbT369, a dual-targeted and CBLB gene edited autologous CAR T for non-Hodgkin lymphoma, showed edit-driven enhanced T cell activity in multiple preclinical models


RESET, a novel TCR coupled... | May 17, 2023

Related Keywords

California , United States , Los Angeles , Philip Gregory , Linkedin , Twitter , Nasdaq , American Society Of Gene Cell Therapy , American Society , Cell Therapy , Annual Meeting , Dimerizing Agent Regulated Immunoreceptor Complex , Seattle Children , Investigational New Drug , 2seventy Bio , Nc Stock Exchange , News , Information , Press Release , End , Kblb , Gene , Sdited , Tautologous , Ear , , Or , Howed , Nhanced , Fell , Activity , N , Multiple , Reclinical , Novel , Cr Tsvt Us9013841070 ,